CONNECTIVE TISSUE RESEARCH

Scope & Guideline

Leading the Charge in Connective Tissue Exploration

Introduction

Welcome to your portal for understanding CONNECTIVE TISSUE RESEARCH, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN0300-8207
PublisherTAYLOR & FRANCIS INC
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1972 to 2024
AbbreviationCONNECT TISSUE RES / Connect. Tissue Res.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106

Aims and Scopes

The journal 'CONNECTIVE TISSUE RESEARCH' focuses on the multidisciplinary study of connective tissues, emphasizing their biology, pathology, and therapeutic approaches. It aims to bridge the gap between basic research and clinical applications, fostering advancements in regenerative medicine and tissue engineering.
  1. Connective Tissue Biology and Physiology:
    Exploration of the molecular and cellular mechanisms underlying the biology of connective tissues, including the roles of various cell types and extracellular matrix components.
  2. Pathophysiology of Connective Tissue Disorders:
    Investigation into the mechanisms of diseases affecting connective tissues, such as osteoarthritis, osteoporosis, and various genetic disorders, aiming to identify potential therapeutic targets.
  3. Regenerative Medicine and Tissue Engineering:
    Research on innovative strategies for the regeneration and repair of connective tissues, including the use of stem cells, biomaterials, and growth factors.
  4. Biomechanics of Connective Tissues:
    Analysis of the mechanical properties of connective tissues and their implications for injury, repair, and functional outcomes.
  5. Immunology and Inflammation in Connective Tissue Diseases:
    Study of the immune responses and inflammatory processes associated with connective tissue disorders, aiming to understand their role in disease progression and treatment.
  6. Translational Research:
    Facilitating the application of basic research findings to clinical practice, particularly in the development of new therapies and interventions for connective tissue diseases.
The journal 'CONNECTIVE TISSUE RESEARCH' has exhibited a dynamic evolution in its thematic focus, with several emerging trends reflecting the latest advancements in the field. These trends indicate the journal's responsiveness to contemporary scientific challenges and opportunities.
  1. Integrative Approaches to Regeneration:
    An increasing number of studies explore the integration of biomaterials, stem cell therapy, and mechanical stimulation for the regeneration of connective tissues, highlighting a multidisciplinary approach to healing.
  2. Molecular Mechanisms of Osteogenesis and Chondrogenesis:
    There is a growing emphasis on understanding the molecular pathways that govern bone and cartilage formation, with research focusing on signaling molecules, transcription factors, and epigenetic modifications.
  3. Role of Extracellular Vesicles in Tissue Repair:
    Research on the therapeutic potential of extracellular vesicles derived from stem cells has gained momentum, providing insights into intercellular communication and regenerative mechanisms.
  4. Biomechanical Assessments and Their Clinical Implications:
    An emerging trend in the journal is the emphasis on biomechanical evaluations and their relevance to clinical outcomes in connective tissue injuries, fostering a better understanding of tissue mechanics.
  5. Personalized Medicine in Connective Tissue Disorders:
    The exploration of personalized therapeutic strategies based on genetic, molecular, and environmental factors is becoming increasingly prominent, reflecting a shift towards tailored treatment approaches.

Declining or Waning

While the journal maintains a robust focus on various aspects of connective tissue research, certain themes have seen a decline in prominence over recent years. This shift may reflect evolving research priorities or advancements in technology that render older methodologies less relevant.
  1. Traditional Surgical Techniques:
    Research emphasizing traditional surgical approaches to connective tissue repair has become less frequent, as newer, less invasive techniques and regenerative therapies gain traction.
  2. In vitro Studies with Limited Clinical Relevance:
    There has been a noticeable decrease in studies that rely solely on in vitro models without subsequent validation in vivo, as there is increasing emphasis on translational research that connects laboratory findings to clinical applications.
  3. Focus on Inflammatory Cytokines Alone:
    Research solely centered on the role of inflammatory cytokines in connective tissue disorders has waned, with a shift towards a more integrated approach that considers multiple signaling pathways and cellular interactions.

Similar Journals

Current Opinion in Biomedical Engineering

Catalyzing breakthroughs in bioengineering fields.
Publisher: ELSEVIERISSN: 2468-4511Frequency: 4 issues/year

Current Opinion in Biomedical Engineering is a renowned journal published by Elsevier, focusing on the cutting-edge developments and critical assessments in the fields of biomedical engineering and related disciplines. With an ISSN of 2468-4511, it provides a valuable platform for researchers and professionals to disseminate their insights and discoveries in areas such as bioengineering, biomaterials, and medicine. Its impressive impact factor positions it in the Q2 category for several fields, including Bioengineering and Biomedical Engineering, highlighting its influence and relevance in ongoing scientific dialogues. The journal’s unique format of opinion pieces and reviews encourages innovative thinking and fosters collaboration among experts. As an essential resource for those engaged in the life sciences and engineering, Current Opinion in Biomedical Engineering serves to stimulate discussion, promote knowledge exchange, and drive advancements in biomedical applications. Set in the Netherlands at Radarweg 29, 1043 NX Amsterdam, the journal is accessible through various academic platforms, enabling a global readership to engage with the latest scholarly work in this dynamic field.

TISSUE & CELL

Bridging Basic Research and Clinical Applications
Publisher: CHURCHILL LIVINGSTONEISSN: 0040-8166Frequency: 6 issues/year

TISSUE & CELL is a prominent academic journal, published by CHURCHILL LIVINGSTONE, that has been at the forefront of research in the fields of cell biology, developmental biology, and miscellaneous areas of medicine since its inception in 1969. With a strong focus on high-quality research, TISSUE & CELL has established itself within the academic community, holding a Q3 ranking in both Cell Biology and Developmental Biology, and a Q2 ranking in Medicine as of 2023. The journal aims to disseminate significant findings that contribute to the understanding of tissue structure and function, helping to bridge the gap between basic biological research and clinical applications. While it operates on a subscription basis and does not currently offer Open Access options, the journal remains a vital resource for researchers, professionals, and students interested in cutting-edge developments in the biological sciences. The journal's address is located in the scenic city of Edinburgh, further establishing its academic heritage in the United Kingdom.

Regenerative Engineering and Translational Medicine

Transforming Research into Real-World Solutions
Publisher: SPRINGER HEIDELBERGISSN: 2364-4133Frequency: 4 issues/year

Regenerative Engineering and Translational Medicine is an esteemed academic journal published by Springer Heidelberg, focusing on the interdisciplinary fields of biomaterials, biomedical engineering, and cell biology. With an ISSN of 2364-4133 and an E-ISSN of 2364-4141, the journal has carved a niche for itself since its inception in 2015, showcasing cutting-edge research that bridges the gap between scientific findings and practical applications in regenerative medicine. As a recognized platform in its field, it is currently positioned within Q3 quartiles in biomaterials, biomedical engineering, and medicine (miscellaneous), with a Scopus ranking that reflects its growing influence among peers. The journal aims to disseminate high-quality, peer-reviewed articles that highlight advancements in regenerative engineering, further advancing both theoretical and applied research. Scholars and practitioners seeking to stay at the forefront of the ever-evolving landscape of regenerative health solutions will find invaluable insights and innovations within these pages. Join a community of leading thinkers and explore the journal's comprehensive research contributions, which are crucial for fostering partnerships between academia and industry in the quest for transformative medical solutions.

Bone Research

Elevating Understanding of Bone Health
Publisher: SPRINGERNATUREISSN: 2095-4700Frequency: 1 issue/year

Bone Research is a premier open-access journal published by SpringerNature, dedicated to advancing the understanding of bone biology and its related disciplines. Established in 2013 and based in the United Kingdom, this journal has quickly ascended to the forefront of scientific inquiry, evidenced by its esteemed Q1 rankings in 2023 across multiple categories including Endocrinology, Diabetes and Metabolism, Histology, and Physiology. With a commendable impact reflected in its Scopus ranks—positioned #2 in Histology, #9 in Endocrinology, and #8 in Physiology—Bone Research serves as a vital platform for researchers, healthcare professionals, and students alike to share and access cutting-edge findings. Since adopting an open-access model in 2014, the journal has empowered an expansive audience by facilitating immediate availability of high-quality research. This aligns with its commitment to foster innovation and collaboration within the fields it encompasses. As it converges its efforts from 2013 to 2024, Bone Research remains a critical resource for those looking to deepen their investigation into bone health and diseases, ensuring its place as a leader in promoting scientific excellence.

Cellular and Molecular Bioengineering

Innovating at the Intersection of Biology and Technology
Publisher: SPRINGERISSN: 1865-5025Frequency: 4 issues/year

Cellular and Molecular Bioengineering, published by SPRINGER, is a prominent journal dedicated to the exploration of interdisciplinary approaches in the fields of biochemistry, genetics, and molecular biology. With an ISSN of 1865-5025 and an E-ISSN of 1865-5033, this journal has been a pivotal resource since its inception in 2009, showcasing groundbreaking research that combines innovative modeling and simulation techniques with cellular and molecular applications. As a Q2 journal in both Biochemistry, Genetics and Molecular Biology (miscellaneous) and Modeling and Simulation categories, it ranks favorably in the Scopus metrics, placing 62nd out of 324 in Mathematics_ Modeling and Simulation, and 69th out of 221 in General Biochemistry, Genetics and Molecular Biology. The journal's commitment to quality research and its contribution to advancing academic dialogue make it essential for researchers, professionals, and students seeking to stay at the forefront of bioengineering innovation. While it currently does not offer open access, it continues to provide significant insights and empirical studies that can help shape future developments in the field, reinforcing its role as a key player in cellular and molecular bioengineering.

Journal of Hard Tissue Biology

Fostering Knowledge in Biochemistry and Biomaterials
Publisher: JOURNAL HARD TISSUE BIOLOGYISSN: 1341-7649Frequency: 4 issues/year

Journal of Hard Tissue Biology, published by JOURNAL HARD TISSUE BIOLOGY, is a pivotal resource for researchers and practitioners engaged in the multifaceted fields of biochemistry, biomaterials, cell biology, dentistry, and orthopedics. With an ISSN of 1341-7649 and a publication history spanning from 2003 to 2024, this journal aims to disseminate innovative findings and review articles that contribute to the understanding of hard tissue structures and their applications in medicine. Despite its current Q4 ranking across several categories, including Biochemistry and Oral Medicine, the journal serves as a critical platform for emerging research, appealing to those dedicated to advancing the science of hard tissues. While it operates under a subscription model, the articles published here are essential for anyone seeking comprehensive insights into the biological, mechanical, and clinical aspects of hard tissues. The journal's commitment to excellence and its ongoing contributions make it an indispensable tool for students, researchers, and professionals aiming to enhance their understanding of hard tissue biology.

Stem Cells International

Empowering Knowledge in Regenerative Biology
Publisher: HINDAWI LTDISSN: 1687-966XFrequency:

Stem Cells International is a premier open access journal published by HINDAWI LTD, focusing on the rapidly evolving field of stem cell research. With an ISSN of 1687-966X and E-ISSN 1687-9678, this journal has been a vital resource since its inception in 2010, showcasing innovative studies and breakthroughs up to 2024. Positioned in Q3 in Cell Biology and Q2 in Molecular Biology for 2023, as well as well-ranked in the Scopus database, the journal serves as an essential platform for researchers, professionals, and students dedicated to exploring the implications of stem cell technology in regenerative medicine and biological research. The open access model ensures wide accessibility, fostering collaboration and knowledge-sharing across the scientific community, making it a cornerstone in advancing the understanding and application of stem cell science.

Journal of Tissue Engineering

Pioneering the Future of Regenerative Medicine
Publisher: SAGE PUBLICATIONS INCISSN: 2041-7314Frequency: 1 issue/year

The Journal of Tissue Engineering, published by SAGE Publications Inc., stands at the forefront of innovation in the interdisciplinary fields of biomaterials and biomedical engineering. Established as an open access journal since 2010, it has quickly ascended to a leading position, as evidenced by its impressive rankings in 2023: Q1 in Biomaterials, Q1 in Biomedical Engineering, and Q1 in Medicine (miscellaneous). With a current impact factor that underscores its academic influence, this journal provides a vital platform for researchers, professionals, and students to share groundbreaking discoveries and advancements in tissue engineering and regenerative medicine. Located in the United Kingdom, the journal fosters a global dialogue with its robust publications and rigorous peer-review process, contributing significantly to the enhancement and understanding of complex biological systems. Join the esteemed community of thought leaders and innovators shaping the future of healthcare through the Journal of Tissue Engineering.

npj Regenerative Medicine

Transforming Science into Healing Solutions.
Publisher: NATURE PORTFOLIOISSN: Frequency: 1 issue/year

npj Regenerative Medicine, published by NATURE PORTFOLIO, is at the forefront of research and innovation in the field of regenerative medicine, fostering a deep understanding of cellular and molecular processes that can be leveraged for therapeutic advancements. Launched as an Open Access journal since 2016, it ensures wide dissemination of knowledge, allowing researchers, professionals, and students to access high-quality articles without barriers. With an impressive impact, it holds Q1 ratings across multiple categories including Biomedical Engineering, Cell Biology, Developmental Biology, and Medicine (miscellaneous) as of 2023, indicating its critical role in shaping contemporary scientific discourse. The journal ranks notably within the top 10% in multiple Scopus categories, indicating its commitment to publishing pioneering research that addresses pressing challenges in regenerative therapies. Addressing the dynamic convergence of disciplines, npj Regenerative Medicine is poised to not only impact academic thought but also translate into clinical applications, making it a pivotal resource for those invested in the future of medicine.

Regenerative Medicine

Charting New Territories in Regenerative Medicine
Publisher: TAYLOR & FRANCIS LTDISSN: 1746-0751Frequency: 12 issues/year

Regenerative Medicine, published by Taylor & Francis Ltd, is a pivotal journal within the field of biomedical research, focusing on the innovative advances in regenerative and restored functions in human health. With an ISSN of 1746-0751 and an E-ISSN of 1746-076X, this esteemed journal boasts a commendable impact factor within its categories, notably holding the Q2 status in Embryology and Q3 in Biomedical Engineering as of 2023. Covering a broad spectrum of topics from stem cell research to tissue engineering, it serves as a crucial platform for interdisciplinary collaboration among researchers, professionals, and students dedicated to the regeneration of tissues and organs. Given its comprehensive scope from 2006 to 2024, the journal continues to attract high-quality manuscripts that advance the frontiers of knowledge in regenerative medicine. Researchers and practitioners alike are encouraged to engage with the latest findings and methodologies disseminated in this vital publication.